Effects of armodafinil and cognitive behavior therapy for insomnia on sleep continuity and daytime sleepiness in cancer survivors
• Cognitive Behavior Therapy for Insomnia (CBT-I) is effective but adherence could be improved.• A wake promoting medication (armodafinil) may help patients adhere to treatment.• CBT-I, with or without armodafinil, improves sleep continuity and sleepiness in cancer survivors.• Armodafinil did not increase adherence to CBT-I recommendations.• Future efforts should focus on identifying those at risk for poor adherence
Source: Sleep Medicine - Category: Sleep Medicine Authors: Sheila N. Garland, Joseph A. Roscoe, Charles E. Heckler, Holly Barilla, Philip Gehrman, James F. Findley, Anita R. Peoples, Gary R. Morrow, Charles Kamen, Michael L. Perlis Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Cognitive Behavior Therapy | Insomnia | Sleep Disorders | Sleep Medicine